首页> 外文期刊>Computer Methods and Programs in Biomedicine: An International Journal Devoted to the Development, Implementation and Exchange of Computing Methodology and Software Systems in Biomedical Research and Medical Practice >Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods
【24h】

Recurrence predictive models for patients with hepatocellular carcinoma after radiofrequency ablation using support vector machines with feature selection methods

机译:支持向量机的特征选择方法对射频消融后肝癌患者的复发预测模型

获取原文
获取原文并翻译 | 示例
           

摘要

Background and objective: Recurrence of hepatocellular carcinoma (HCC) is an important issue despite effective treatments with tumor eradication. Identification of patients who are at high risk for recurrence may provide more efficacious screening and detection of tumor recurrence. The aim of this study was to develop recurrence predictive models for HCC patients who received radiofrequency ablation (RFA) treatment. Methods: From January 2007 to December 2009, 83 newly diagnosed HCC patients receiving RFA as their first treatment were enrolled. Five feature selection methods including genetic algorithm (GA), simulated annealing (SA) algorithm, random forests (RF) and hybrid methods (GA+RF and SA+RF) were utilized for selecting an important subset of features from a total of 16 clinical features. These feature selection methods were combined with support vector machine (SVM) for developing predictive models with better performance. Five-fold cross-validation was used to train and test SVM models. Results: The developed SVM-based predictive models with hybrid feature selection methods and 5-fold cross-validation had averages of the sensitivity, specificity, accuracy, positive predictive value, negative predictive value, and area under the ROC curve as 67%, 86%, 82%, 69%, 90%, and 0.69, respectively. Conclusions: The SVM derived predictive model can provide suggestive high-risk recurrent patients, who should be closely followed up after complete RFA treatment.
机译:背景与目的:尽管有效的根除肿瘤治疗方法,肝细胞癌(HCC)的复发仍是一个重要的问题。鉴定高复发风险的患者可以提供更有效的筛查和肿瘤复发检测。这项研究的目的是为接受射频消融(RFA)治疗的HCC患者建立复发预测模型。方法:自2007年1月至2009年12月,纳入83例接受RFA首次治疗的新诊断HCC患者。利用遗传算法(GA),模拟退火(SA)算法,随机森林(RF)和混合方法(GA + RF和SA + RF)的五种特征选择方法从总共16种临床中选择重要的特征子集特征。这些特征选择方法与支持向量机(SVM)相结合,以开发性能更好的预测模型。五重交叉验证用于训练和测试SVM模型。结果:已开发的具有混合特征选择方法和5倍交叉验证的基于SVM的预测模型的敏感性,特异性,准确性,阳性预测值,阴性预测值和ROC曲线下面积的平均值为67%,86分别为%,82%,69%,90%和0.69。结论:SVM衍生的预测模型可提供提示高危复发的患者,在完全RFA治疗后应密切随访。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号